Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy
Zakile A. Mfumbilwa, Martijn J.H.G. Simons, Bram Ramaekers, Valesca P. Retèl, Joanne M. Mankor, Harry J.M. Groen, Joachim G.J.V. Aerts, Manuela Joore, Janneke A. Wilschut, Veerle M.H. Coupé*
Research output: Contribution to journal › Article › Academic › peer-review
4Citations
(Scopus)
43Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy'. Together they form a unique fingerprint.